Multiple Sclerosis Clinical Trials in Houston, TX

13 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)	Phase 3	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis	Phase 1	Amylyx Pharmaceuticals Inc.	<1 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO	Phase 1	National Cancer Institute (NCI)	<1 mi
TSC Biosample Repository and Natural History Database	—	National Tuberous Sclerosis Association	<1 mi
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study	Phase 2	Darcy Krueger	<1 mi
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study	N/A	SetPoint Medical Corporation	<1 mi
Care in Multiple Sclerosis (MS)	—	NYU Langone Health	<1 mi
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS	N/A	The Methodist Hospital Research Institute	<1 mi
Multiple Sclerosis Implementation Network (Registry)	—	The University of Texas Health Science Center, Houston	<1 mi
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab	Phase 3	TG Therapeutics, Inc.	<1 mi
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis	Phase 4	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Study of COYA 302 for the Treatment of ALS	Phase 2	Coya Therapeutics	<1 mi
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease	—	TScan Therapeutics, Inc.	7 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.